TW200500073A - Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof - Google Patents

Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof

Info

Publication number
TW200500073A
TW200500073A TW093103888A TW93103888A TW200500073A TW 200500073 A TW200500073 A TW 200500073A TW 093103888 A TW093103888 A TW 093103888A TW 93103888 A TW93103888 A TW 93103888A TW 200500073 A TW200500073 A TW 200500073A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
indolopyrrolocarbazole derivative
indolopyrrolocarbazole
derivative
edotecarin
Prior art date
Application number
TW093103888A
Other languages
English (en)
Chinese (zh)
Inventor
Marina Ciomei
Enrico Pesenti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of TW200500073A publication Critical patent/TW200500073A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
TW093103888A 2003-02-21 2004-02-18 Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof TW200500073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (it) 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.

Publications (1)

Publication Number Publication Date
TW200500073A true TW200500073A (en) 2005-01-01

Family

ID=32894164

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093103888A TW200500073A (en) 2003-02-21 2004-02-18 Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof

Country Status (10)

Country Link
EP (1) EP1599210A1 (fr)
JP (1) JP2006518355A (fr)
AR (1) AR043241A1 (fr)
BR (1) BRPI0407642A (fr)
CA (1) CA2516097A1 (fr)
CL (1) CL2004000319A1 (fr)
IT (1) ITMI20030317A1 (fr)
MX (1) MXPA05008879A (fr)
TW (1) TW200500073A (fr)
WO (1) WO2004073719A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007307080B2 (en) * 2006-10-06 2014-01-09 Bavarian Nordic A/S Methods for treating cancer with MVA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
EE200200471A (et) * 2000-02-28 2003-12-15 Aventis Pharma S.A. Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks

Also Published As

Publication number Publication date
ITMI20030317A1 (it) 2004-08-22
AR043241A1 (es) 2005-07-20
WO2004073719A1 (fr) 2004-09-02
BRPI0407642A (pt) 2006-03-01
MXPA05008879A (es) 2005-10-05
EP1599210A1 (fr) 2005-11-30
CA2516097A1 (fr) 2004-09-02
JP2006518355A (ja) 2006-08-10
CL2004000319A1 (es) 2005-04-22

Similar Documents

Publication Publication Date Title
LUC00011I1 (fr)
MXPA05013642A (es) Composicion de un antagonista de vegf y un agente antiproliferativo y su uso para el tratamiento de cancer.
TW200612987A (en) Combination treatment for non-hematologic malignancies
WO2007062093A3 (fr) Polytherapie pour le traitement du cancer
SG166775A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
WO2005058233A3 (fr) Methodes de traitement d'une pancreatite aigue
TW200633700A (en) Methods of using temozolomide formulation intrathecally in the treatment of cancers
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
EP1503748A4 (fr) Medicaments servant a attenuer la neurotoxicite induite par le taxane
NO20064753L (no) Kombinasjonsterapi
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
WO2007146375A3 (fr) Composés de pyrimido-dione-quinoléine hautement solubles et procédés de traitement du cancer
MXPA05004917A (es) Combinacion que comprende docetaxel y un inhibidor cdk.
MXPA04009012A (es) Combinacion de inhibidor ofa cdk y 5 fu para el tratamiento de cancer.
BRPI0409870A (pt) uso de irinotecano para tratamento de cáncer de mama resistente
MXPA05013827A (es) Composiciones que comprenden zd6126 junto con 5-fu, cpt-11 o 5-fu y cpt-11, que tienen actividad de dano vascular, para tratar cancer colorectal e. g.
NO20051601L (no) Kombinasjonsterapi med gemcitabin og zd6126